Bio Protocol vs Hyperliquid — how do they compare? Bio Protocol trades at Rp513.8 (market cap Rp1,16T, Rp252,63M 24h volume), while Hyperliquid trades at Rp1,158,949 (market cap Rp293,38T, Rp5,88T 24h volume). The key difference: Hyperliquid is far larger — about 252.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 253,1M / 953,3M HYPE (27%) for Hyperliquid. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Hyperliquid for 34 Days on average.
| BIO | HYPE | |
|---|---|---|
Market Cap | Rp1,16T | Rp293,38T |
Volume (24h) | Rp252,63M | Rp5,88T |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 253,1M / 953,3M HYPE (27%) |
Typical Hold Time | 16 Days | 34 Days |
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Hyperliquid is an advanced blockchain platform designed to improve the efficiency and performance of decentralized finance (DeFi) applications. It is built on a custom Layer 1 blockchain that has been specifically engineered for optimal scalability and speed. A key feature of its design is HyperBFT, a proprietary consensus mechanism that provides rapid transaction finality while ensuring high security standards.
Read more on HYPE →